Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
Florida Cancer Specalists, Sarasota, Florida Memorial Sloan Kettering Cancer Center, New York, New York The University of Texas MD Anderson Cancer Center, Houston, Texas University of Texas at Tyler, Tyler, Texas NEXT Virginia, Fairfax, Virginia